The store will not work correctly when cookies are disabled.
5,10-dihydro-2H-benzo[6,7]thiochromeno[2,3-d][1,3]thiazole-2,5,10-trione
ID: ALA4163382
PubChem CID: 43842554
Max Phase: Preclinical
Molecular Formula: C14H5NO3S2
Molecular Weight: 299.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1c2ccccc2C(=O)c2sc3nc(=O)sc-3cc21
Standard InChI: InChI=1S/C14H5NO3S2/c16-10-6-3-1-2-4-7(6)11(17)12-8(10)5-9-13(20-12)15-14(18)19-9/h1-5H
Standard InChI Key: GXCHGNRASGQSTG-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
16.2253 -7.6491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2241 -8.4759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9385 -8.8885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9367 -7.2365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6516 -7.6454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6505 -8.4733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3630 -8.8861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3653 -7.2302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3606 -9.7105 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3653 -6.4057 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0823 -7.6475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0789 -8.4733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7884 -8.8870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7954 -7.2352 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
20.5095 -7.6534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5078 -8.4761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2896 -8.7319 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.7746 -8.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2924 -7.4009 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.5991 -8.0691 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 8 1 0
6 7 1 0
7 12 1 0
11 8 1 0
7 9 2 0
8 10 2 0
11 12 2 0
11 14 1 0
12 13 1 0
13 16 2 0
15 14 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 15 2 0
18 20 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 299.33 | Molecular Weight (Monoisotopic): 298.9711 | AlogP: 2.45 | #Rotatable Bonds: ┄ |
Polar Surface Area: 64.10 | Molecular Species: ┄ | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.14 | CX LogD: 2.14 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.50 | Np Likeness Score: -0.19 |
References
1. Szychowski KA, Leja ML, Kaminskyy DV, Kryshchyshyn AP, Binduga UE, Pinyazhko OR, Lesyk RB, Tobiasz J, Gmiński J.. (2017) Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ)., 141 [PMID:29031063] [10.1016/j.ejmech.2017.09.071] |